Does RISPERIDONE Cause Injection site discolouration? 7 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Injection site discolouration have been filed in association with RISPERIDONE (Risperidone). This represents 0.0% of all adverse event reports for RISPERIDONE.
7
Reports of Injection site discolouration with RISPERIDONE
0.0%
of all RISPERIDONE reports
0
Deaths
2
Hospitalizations
How Dangerous Is Injection site discolouration From RISPERIDONE?
Of the 7 reports, 2 (28.6%) required hospitalization.
Is Injection site discolouration Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RISPERIDONE. However, 7 reports have been filed with the FAERS database.
What Other Side Effects Does RISPERIDONE Cause?
Gynaecomastia (24,453)
Off label use (10,376)
Abnormal weight gain (9,418)
Weight increased (6,885)
Emotional disorder (5,809)
Product use in unapproved indication (5,551)
Drug ineffective (5,232)
Injury (4,447)
Hyperprolactinaemia (4,124)
Galactorrhoea (3,513)
What Other Drugs Cause Injection site discolouration?
ETANERCEPT (1,846)
DUPILUMAB (779)
CERTOLIZUMAB PEGOL (597)
ADALIMUMAB (554)
EVOLOCUMAB (476)
GLATIRAMER (270)
EXENATIDE (266)
TERIPARATIDE (249)
ASFOTASE ALFA (243)
ENBREL (231)
Which RISPERIDONE Alternatives Have Lower Injection site discolouration Risk?
RISPERIDONE vs RITALIN
RISPERIDONE vs RITLECITINIB
RISPERIDONE vs RITODRINE
RISPERIDONE vs RITONAVIR
RISPERIDONE vs RITUXAN